Pharmacometabolomicsc of docetaxel-treated human MCF7 breast cancer cells provides evidence of varyi...
Pharmacometabolomicsc of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses
About this item
Full title
Author / Creator
Publisher
Springer
Journal title
Language
English
Formats
Publication information
Publisher
Springer
Subjects
More information
Scope and Contents
Contents
There is growing evidence that docetaxel, a microtubule-targeting agent like the other taxane paclitaxel, induces dual cytotoxicity mechanism according to dose level. Postgenomics screening technologies are now more and more applied to the elucidation of drug response mechanisms. Proton nuclear magnetic resonance spectroscopy-based pharmacometabolo...
Alternative Titles
Full title
Pharmacometabolomicsc of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A356039261
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A356039261
Other Identifiers
ISSN
0167-6806
DOI
10.1007/s10549-009-0430-1
